EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

International Expert Consensus on Demulcents as Mucosal Barriers in Upper Respiratory Tract Infections

Ratko Prstačić, Elvia Molano, María J Cuadrado, Inga Trompetter, Natalia Machajewski, Eric Martin, Simon Braun iD

Ear, Nose & Throat Journal · 26.10.2026

DOI: 10.1177/01455613261499463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ear, Nose & Throat Journal, online erschienen am 26.10.2026. Verfasst von Ratko Prstačić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of ENT and Head and Neck Surgery, University Clinical Hospital Center, Zagreb, Croatia. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Engelhard Arzneimittel GmbH & Co. KG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Demulcents form protective mucoadhesive films on oropharyngeal mucosa and provide symptomatic relief in upper respiratory tract infections, yet their mode of action, clinical indications, and desirable properties remain poorly defined. An international advisory board convened on 19 February 2026 comprising experts in otorhinolaryngology, phoniatrics, and pharmacology from Germany, Croatia, Colombia, and Ecuador. The panel reviewed preclinical data, alongside targeted literature evidence, and discussed clinical experiences with demulcents and their use in patients. Major findings Reviewed clinical studies suggested symptomatic benefit, particularly in reducing throat irritation, dryness, and cough-associated discomfort, although the available evidence remains limited. Consensus was achieved across four domains: (I) mechanism of action - local physical barrier formation through mucoadhesive film; (II) clinical indications - common cold with sore throat and dry cough, laryngopharyngeal reflux, vocal fatigue, allergy-related irritation, and post-operative throat discomfort; (III) desirable properties - rapid onset, prolonged mucosal contact, acceptable taste, and broad safety profile; (IV) research priorities - prospective studies evaluating complication reduction using symptom scales and objective endpoints such as antibiotic prescriptions and healthcare utilization.

Conclusions

Together, experts agreed that demulcents represent a rational treatment approach to symptomatic upper respiratory symptom management through local barrier formation.

Schlagwörter

Stichwörter der Autor:innen

Demulcentslaryngopharyngeal refluxmucoadhesionrhinovirusupper respiratory tract infectionvocal fatigue

Autor:innen und Institutionen

  • Department of ENT and Head and Neck Surgery, University Clinical Hospital Center, Zagreb, Croatia.
  • University of Zagreb School of Medicine, Croatia.
  • Private Practice, Centro Médico Vital, Barranquilla, Colombia.
  • Department of Otorhinolaryngology, Fundasen Hospital del Día, Guayaquil, Ecuador.
  • Scientific Affairs, Engelhard Arzneimittel, Niederdorfelden, Germany.
  • Hubertus Apotheke, Marktheidenfeld, Germany.

ORCID-Profile: Simon Braun

Förderung

  • Engelhard Arzneimittel GmbH & Co. KG

Zitieren

APA

Prstačić, R., Molano, E., Cuadrado, M. J., Trompetter, I., Machajewski, N., Martin, E., & Braun, S. (2026). International Expert Consensus on Demulcents as Mucosal Barriers in Upper Respiratory Tract Infections. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613261499463

Vancouver

Prstačić R, Molano E, Cuadrado MJ, Trompetter I, Machajewski N, Martin E, et al. International Expert Consensus on Demulcents as Mucosal Barriers in Upper Respiratory Tract Infections. Ear, Nose & Throat Journal. 2026. doi:10.1177/01455613261499463

BibTeX
@article{Prstai2026,
  author = {Prstačić, Ratko and Molano, Elvia and Cuadrado, María J and Trompetter, Inga and Machajewski, Natalia and Martin, Eric and Braun, Simon},
  title = {International Expert Consensus on Demulcents as Mucosal Barriers in Upper Respiratory Tract Infections},
  journal = {Ear, Nose & Throat Journal},
  year = {2026},
  doi = {10.1177/01455613261499463}
}
Kostenlos starten →